Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/27165
Title: | Totally Occluded Culprit Coronary Artery in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. | Austin Authors: | Fernando, Himawan;Duffy, Stephen J;Low, Ashlea;Dinh, Diem;Adrianopoulos, Nick;Sharma, Anand;Peter, Karlheinz;Stub, Dion;Leong, Kai'En;Ajani, Andrew;Clark, David J ;Freeman, Melanie;Sebastian, Martin;Brennan, Angela;Selkrig, Laura;Reid, Christopher M;Kaye, David;Oqueli, Ernesto | Affiliation: | School of Public Health, Curtin University, Perth, Western Australia, Australia Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia Department of Cardiology, Box Hill Hospital, Melbourne, Victoria, Australia Cardiology Department of Cardiology, Barwon Health, Geelong, Victoria, Australia Department of Cardiology, Alfred Hospital, Melbourne, Australia Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia Baker Heart and Diabetes Institute, Melbourne, Australia Department of Cardiology, Ballarat Health Services, Ballarat, Victoria, Australia Central Clinical School, Monash University, Melbourne, Australia School of Medicine, Faculty of Health, Deakin University, Geelong, Victoria, Australia |
Issue Date: | 1-Oct-2021 | Date: | 2021-08-03 | Publication information: | The American Journal of Cardiology 2021; 156: 52-57 | Abstract: | The short- and long-term implications of identifying totally occluded culprit coronary arteries (TOCCA) in patients presenting with non-ST-elevation myocardial infarction (NSTEMI) have not been well studied. This study compares clinical characteristics, short- and long-term outcomes of patients with NSTEMI identified with TOCCA to that of patients with non-TOCCA undergoing percutaneous coronary intervention (PCI). We analyzed data from patients with NSTEMI undergoing single-vessel PCI within the Melbourne Interventional Group multi-center registry between 2005 and 2017. Those with TOCCA were compared to those with non-TOCCA. The primary endpoint was 30-day major adverse cardiac events (MACE). Secondary endpoints included 12-month MACE and long-term mortality. A total of 6,829 patients with NSTEMI had single-vessel PCI of which 954 (14%) had TOCCA. Most TOCCA were non-left anterior descending (right coronary artery 39% versus circumflex 33% versus left anterior descending 26%; p <0.001). Cardiogenic shock and left ventricular dysfunction were higher in the TOCCA group, but non-TOCCA patients had more baseline comorbidities. Thirty-day MACE was higher in the TOCCA group (6.7% versus 3.8%; p <0.001). Long-term mortality with an average follow-up of 4.9 years was higher in the non-TOCCA group (12% versus 18%, p <0.01). Multivariable Cox-proportional hazards regression identified TOCCA as an independent predictor of 30-day MACE (HR = 1.93; 95%CI: 1.4-2.6), but not long-term mortality, which was predicted by baseline comorbidities. In conclusion, while patients with NSTEMI with TOCCA undergoing PCI represent a more unstable subgroup early on, long-term outcomes appear more dependent on baseline comorbidities. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/27165 | DOI: | 10.1016/j.amjcard.2021.06.043 | Journal: | The American Journal of Cardiology | PubMed URL: | 34362552 | Type: | Journal Article | Subjects: | Myocardial Infarction Percutaneous Coronary Intervention |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.